Geometric mean anti-
B hepatitis B
Per-protocol immunogenicity population. Vaccinations were administered on study days 1, 57, and 113. Error bars represent 95% confidence intervals. Euvax B hepatitis B recipients were pooled across cohorts.Only 1 comparator vaccine recipient developed a significant rise in anti-There were significantly more (86%) antigen-specific IgG responders in the 100 μg with AP 10–701 group than in the comparator vaccine (8%) group (